rs201021891
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM2BP4_StrongBP6_Very_Strong
The NM_006073.4(TRDN):c.367G>A(p.Asp123Asn) variant causes a missense change. The variant allele was found at a frequency of 0.000334 in 1,572,536 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_006073.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000336 AC: 51AN: 151894Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000679 AC: 140AN: 206190Hom.: 0 AF XY: 0.000574 AC XY: 64AN XY: 111460
GnomAD4 exome AF: 0.000334 AC: 475AN: 1420642Hom.: 1 Cov.: 35 AF XY: 0.000336 AC XY: 237AN XY: 704412
GnomAD4 genome AF: 0.000336 AC: 51AN: 151894Hom.: 0 Cov.: 31 AF XY: 0.000324 AC XY: 24AN XY: 74174
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:2
This patient is a 14-year old female with a history of chronic dizziness and one episode of VT detected on Holter. She had an Arrhythmia and Cardiomyopathy Comprehensive Panel with the Invitae Laboratory. The following genes were evaluated for sequence changes and exonic deletions/duplications: ABCC9, ACTC1, ACTN2, AGL, AKAP9, ANK2, ANKRD1, BAG3, CACNA1C, CACNA2D1, CACNB2, CALM1, CALM2, CALM3, CALR3, CASQ2, CAV3, CHRM2, CRYAB, CSRP3, CTF1, CTNNA3, DES, DMD, DOLK, DSC2, DSG2, DSP, DTNA, EMD, EYA4, FHL1, FHL2, FKRP, FKTN, FLNC, GAA, GATA4, GATA6, GATAD1, GJA5, GLA, GPD1L, HCN4, ILK, JPH2, JUP, KCNA5, KCND3, KCNE1, KCNE2, KCNE3, KCNE5, KCNH2, KCNJ2, KCNJ5, KCNJ8, KCNK3, KCNQ1, LAMA4, LAMP2, LDB3, LMNA, LRRC10, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYL4, MYLK2, MYOM1, MYOZ2, MYPN, NEBL, NEXN, NKX2-5, NPPA, PDLIM3, PKP2, PLEKHM2, PLN, PRDM16, PRKAG2, RAF1, RANGRF, RBM20, RYR2, SCN10A, SCN1B, SCN2B, SCN3B, SCN4B, SCN5A, SGCD, SLC22A5, SLMAP, SNTA1, TAZ, TCAP, TGFB3, TMEM43, TMPO, TNNC1, TNNI3, TNNT2, TPM1, TRDN, TRPM4, TTN, TTR, TXNRD2, VCL. Results indicate that two variants were detected: p.Asp123Asn (D123N; c.367G>A) in the TRDN gene p.Arg696Cys (c.2086C>T) in the MYOM1 gene We do not currently suspect that either of these is the cause of her episodes of dizziness and VT. p.Asp123Asn (D123N; c.367G>A) in exon 3 of the TRDN gene (NM_006073.3) Chromosome position 6:123869623 C / T The TRDN gene causes an autosomal recessive form of LQTS and CPVT. No second variant was reported in the patient’s other TRDN allele. Invitae classifies p.Asp123Asn as a Variant of Uncertain Signficance (VUS). As of 5/22/2017 it has been reported to ClinVar as a VUS by Ambry, GeneDx, and Illumina as well. Based on the information reviewed below, including its high frequency among the Ashkenazi Jewish population, and the fact that it is not a truncating mutation, we classify it as a VUS, probably benign, concluding that there is not sufficient evidence for its pathogenicity to warrant using it for diagnosis or predictive genetic testing. This variant has not previously been reported in the literature in association with disease. Typically, pathogenic TRDN variants are truncating (frameshift, splice site, or nonsense) rather than a missense variant such as this one. This is a nonconservative amino acid change, resulting in the replacement of a negatively-charged Aspartic Acid with a polar Asparagine. Aspartic Acid at this location is not conserved across ~100 vertebrate species for which we have data, and a Glutamic Acid (with similar properties) at this site is equally likely. The adjacent residues are also not conserved. There is currently no missense variation at nearby residues (+/- 10 amino acids) listed in ClinVar as Likely Pathogenic or Pathogenic. According to the Invitae report, algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Unknown"; AlignGVGD: "Class C0"). This variant was reported in 141 individuals in the gnomAD database, which includes variant calls on ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. Overall allele frequency 0.06%. Specifically, the variant was observed in 117/4,326 people with Ashkenazi Jewish ancestry (for the highest allele frequency: 1.35%), and also in 11/53,136 people with European (non-Finnish) ancestry for allele frequency 0.01%, as well as in 4 Latinos, 1 African-ancestry, and 8 “other†individuals. There are also 5 individuals with an in-frame deletion of Asp123 in gnomAD. The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. Our patient’s ancestry -
TRDN: BP4 -
This variant is associated with the following publications: (PMID: 31341780) -
Catecholaminergic polymorphic ventricular tachycardia 1;C3809536:Catecholaminergic polymorphic ventricular tachycardia 5 Benign:1
- -
Catecholaminergic polymorphic ventricular tachycardia 1 Benign:1
- -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at